Tax Payers Unite and Say That Blue Tax's SUCKS Program is a Refreshing New Approach to Owing Taxes

"So U Can Kick Start" program is making waves throughout the tax industry.

2013-06-02

LOS ANGELES, CA, June 02, 2013 (Press-News.org) Never before has such an innovative and outside the box program been dreamed up by a boring tax company. Blue Tax has always been known for their creative, animated marketing approach in their commercial, print and radio advertisements. Love it or hate it, you remember it. Blue Tax has now gone over the top with their new tax program that they have entitled "SUCKS." An acronym for "So U Can Kick Start," the program identifies with tax payers who have found themselves in a debilitating tax situation. The program offers a free phone analysis to every delinquent tax payer, no matter the size of the amount. Blue Tax will advise folks as to whether it would be best to handle the problem on their own or hire representation. The S.U.C.K.S. Program is designed to give people the kick in the butt they need to handle their tax issues.

"Let's face it, owing taxes sucks. There is no way to sugarcoat it," says Todd Lewis Vice President of Blue Tax. "We have found that when people owe, they don't want to deal with it. They put it on the back burner and it really affects their lives. We want people to know, we here at Blue Tax get it, but the worst thing you can do is to stick your head in the sand." Blue Tax knows that addressing a tax problem early is the best way to approach things. Since launching the S.U.C.K.S. program, Blue Tax has been inundated with calls from all over the country. Blue Tax has been praised for their innovative approach to get people to stop procrastinating and start dealing with their tax issues.

Blue Tax invites anyone dealing with a delinquent tax issue to take advantage of their S.U.C.K.S. program and call today for a free consultation. Assistance is available Monday through Friday 6am to 6pm Pacific Standard Time. Blue Tax representatives are the friendliest in the industry and will help point tax payers in the right direction.

For more information about Blue Tax and its ability to help businesses and taxpayers alike, please visit www.BlueTax.com or call (800) 780-8485 for a free confidential consultation.

ELSE PRESS RELEASES FROM THIS DATE:

MGH-led studies shed new light on targeted lung cancer therapy

2013-06-01

Research teams led by Massachusetts General Hospital (MGH) Cancer Center investigators are publishing two important studies regarding use of the targeted cancer drug crizotinib for treatment of advanced lung cancer driven by specific genetic mutations. The first reports the final results of a global, phase 3 trial showing that crizotinib is superior to standard chemotherapy for treatment of advanced ALK-positive non-small cell lung cancer (NSCLC). The second paper describes the first report of resistance to crizotinib treatment in a patient with ROS1-positive NSCLC and ...

Spousal oral HPV, predictors of melanoma and throat cancer, preventing cancer readmissions

2013-06-01

Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2013 American Society of Clinical Oncology (ASCO) meeting May 31-June 4, 2013 in Chicago, including data on the likelihood of spousal human papillomavirus (HPV) oral infection, new gene signatures in melanoma, and issues with high readmission rates after cancer surgery. Highlights of Mount Sinai research at ASCO: Oral HPV Not Prevalent in Spouses of People with HPV-Positive Throat Cancer (Under Embargo Until 6:30 AM CDT on Saturday, June 1, 2013) In the first study of its ...

Targeted therapy boosts lung cancer outcomes

2013-06-01

BOSTON––Thousands of patients with an advanced form of lung cancer that carries a specific dysfunctional gene are likely to fare better if treated with a targeted therapy than with traditional chemotherapy, report Dana-Farber Cancer Institute researchers and a team of international collaborators. In a trial involving patients with non-small cell lung cancer (NSCLC) whose tumor cells harbored an abnormal ALK gene, those who received the oral drug crizotinib, which acts directly on ALK, went a median time of 7.7 months before their disease began to worsen, compared to 3 ...

New drug improves progression-free survival, shrinks tumors in rare cancer for first time

2013-06-01

CHICAGO, JUNE 1, 2013 — The experimental drug selumetinib is the first targeted therapy to demonstrate significant clinical benefit for patients with metastatic uveal melanoma, according to new Memorial Sloan-Kettering Cancer Center research presented on Saturday, June 1, at the 49th annual meeting of the American Society of Clinical Oncology (ASCO). The findings are potentially practice-changing for a historically "untreatable disease." Though uveal melanoma is rare — there are only 2,500 cases diagnosed in the United States each year — about half of patients will develop ...

No increased risk of infection for long-term sex partners of people with HPV-related oral cancers

2013-06-01

Spouses and long-term partners of patients with mouth and throat cancers related to infection with the human papilloma virus (HPV) appear to have no increased prevalence of oral HPV infections, according to results of a multicenter, pilot study led by Johns Hopkins investigators. The study's results suggest that long-term couples need not change their sexual practices, say the scientists. "While we can't guarantee that the partners of patients will not develop oral HPV infections or cancers, we can reassure them that our study found they had no increased prevalence of ...

Acidifying oceans could spell trouble for squid

2013-06-01

Acidifying oceans could dramatically impact the world's squid species, according to a new study led by Woods Hole Oceanographic Institution (WHOI) researchers and soon to be published in the journal PLOS ONE. Because squid are both ecologically and commercially important, that impact may have far-reaching effects on the ocean environment and coastal economies, the researchers report. "Squid are at the center of the ocean ecosystem—nearly all animals are eating or eaten by squid," says WHOI biologist T. Aran Mooney, a co-author of the study. "So if anything happens to ...

Procedures saving limbs of more peripheral arterial disease patients, Mayo Clinic finds

2013-06-01

SAN FRANCISCO -- Peripheral arterial disease is a common circulation problem in which reduced blood flow can lead to complications that jeopardize the limbs, possibly even requiring amputation. Procedures known as revascularization have reduced the need for amputations 40 percent over two decades, Mayo Clinic research shows. The findings were among several studies presented at the Society for Vascular Surgery annual meeting in San Francisco. In the amputation study, Mayo researchers analyzed patients in the Rochester Epidemiology Project, a National Institutes of ...

Exposure to general anaesthesia could increase the risk of dementia in elderly by 35 percent

2013-06-01

Exposure to general anaesthesia increases the risk of dementia in the elderly by 35%, says new research presented at Euroanaesthesia, the annual congress of the European Society of Anaesthesiology (ESA). The research is by Dr Francois Sztark, INSERM and University of Bordeaux, France, and colleagues. Postoperative cognitive dysfunction, or POCD, could be associated with dementia several years later. POCD is a common complication in elderly patients after major surgery. It has been proposed that there is an association between POCD and the development of dementia due ...

Catastrophic climatic events leave corals facing a decade-long fight for recovery

2013-06-01

Marine conservationists from Plymouth University, and the Universidad Federal da Bahia in Brazil, have spent more than 17 years analysing the diversity and density of coral colonies off the coast of South America. That coincided with the catastrophic El Niño event of 1997-98, creating an opportunity for the first detailed assessment of the long-term impact a major environmental incident of this nature can have on coral assemblages. Professor Martin Attrill, Director of Plymouth University's Marine Institute, said: "Coral reefs are perhaps the most diverse marine ecosystem ...

Oncogene mutation hijacks splicing process to promote growth and survival

2013-06-01

An international team of researchers – led by principal investigator Paul S. Mischel, MD, a member of the Ludwig Institute for Cancer Research and professor in the Department of Pathology at the University of California, San Diego School of Medicine – has found that a singular gene mutation helps brain cancer cells to not just survive, but grow tumors rapidly by altering the splicing of genes that control cellular metabolism. The findings are published online in the journal Cell Metabolism. Mischel, who heads the Ludwig Institute's molecular pathology laboratory based ...

LAST 30 PRESS RELEASES:

SNU researchers develop world’s first technology to observe atomic structural changes of nanoparticles in 3D

SNU researchers develop a new synthesis technology of single crystal 2D semiconductors, “Hypotaxy,” to enhance the commercialization of next-generation 2D semiconductors